tiprankstipranks
Trending News
More News >
Ligand Pharmaceuticals Inc (LGND)
:LGND
US Market
Advertisement

Ligand Pharma (LGND) Ratios

Compare
818 Followers

Ligand Pharma Ratios

LGND's free cash flow for Q1 2025 was $0.89. For the 2025 fiscal year, LGND's free cash flow was decreased by $ and operating cash flow was $-1.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.27 14.15 2.67 11.15 5.00
Quick Ratio
5.02 12.72 2.53 10.50 4.74
Cash Ratio
0.82 1.37 <0.01 0.47 0.48
Solvency Ratio
-0.89 1.03 0.23 0.21 0.04
Operating Cash Flow Ratio
0.90 2.95 1.40 1.89 0.55
Short-Term Operating Cash Flow Coverage
59.81 0.00 1.80 0.00 0.00
Net Current Asset Value
$ 199.41M$ 151.13M$ 98.42M$ -15.00M$ -152.20M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.12 0.26 0.33
Debt-to-Equity Ratio
<0.01 <0.01 0.15 0.41 0.64
Debt-to-Capital Ratio
<0.01 <0.01 0.13 0.29 0.39
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.28 0.38
Financial Leverage Ratio
1.14 1.12 1.28 1.58 1.92
Debt Service Coverage Ratio
-20.17 138.71 0.17 7.65 2.79
Interest Coverage Ratio
-16.44 18.20 -14.18 4.21 0.31
Debt to Market Cap
<0.01 0.00 0.07 0.12 0.27
Interest Debt Per Share
0.43 0.39 5.31 21.35 29.78
Net Debt to EBITDA
0.36 -0.17 1.61 2.38 5.89
Profitability Margins
Gross Profit Margin
82.73%73.31%73.08%77.56%83.68%
EBIT Margin
-86.70%48.98%19.27%33.13%15.40%
EBITDA Margin
-67.28%76.79%27.72%48.05%37.04%
Operating Profit Margin
-34.06%9.09%-13.00%28.47%4.59%
Pretax Profit Margin
-88.77%48.48%18.35%17.07%-5.65%
Net Profit Margin
-73.07%39.72%-2.66%20.62%-1.60%
Continuous Operations Profit Margin
-73.07%40.98%-2.66%27.55%3.54%
Net Income Per EBT
82.32%81.93%-14.49%120.80%28.33%
EBT Per EBIT
260.65%533.08%-141.20%59.95%-123.25%
Return on Assets (ROA)
-14.65%6.63%-0.68%4.39%-0.22%
Return on Equity (ROE)
-16.36%7.44%-0.87%6.95%-0.42%
Return on Capital Employed (ROCE)
-7.30%1.55%-3.84%6.26%0.68%
Return on Invested Capital (ROIC)
-6.00%1.31%0.50%7.62%0.19%
Return on Tangible Assets
-24.31%16.46%-1.71%10.27%-0.53%
Earnings Yield
-5.44%4.22%-0.46%2.22%-0.19%
Efficiency Ratios
Receivables Turnover
4.71 3.34 5.60 3.02 3.16
Payables Turnover
5.84 14.44 9.95 7.40 8.04
Inventory Turnover
2.14 1.46 3.97 2.28 1.15
Fixed Asset Turnover
17.30 5.24 13.08 8.46 8.20
Asset Turnover
0.20 0.17 0.26 0.21 0.14
Working Capital Turnover Ratio
0.67 0.68 0.67 0.67 0.25
Cash Conversion Cycle
185.11 333.61 120.35 231.79 388.06
Days of Sales Outstanding
77.41 109.27 65.17 120.70 115.64
Days of Inventory Outstanding
170.18 249.61 91.85 160.42 317.82
Days of Payables Outstanding
62.49 25.27 36.67 49.33 45.40
Operating Cycle
247.59 358.88 157.02 281.12 433.46
Cash Flow Ratios
Operating Cash Flow Per Share
2.75 2.87 8.17 4.74 3.37
Free Cash Flow Per Share
1.85 -0.25 7.11 4.21 3.10
CapEx Per Share
0.90 0.20 1.06 0.53 0.28
Free Cash Flow to Operating Cash Flow
0.67 -0.09 0.87 0.89 0.92
Dividend Paid and CapEx Coverage Ratio
3.05 14.08 7.69 8.99 12.24
Capital Expenditure Coverage Ratio
3.05 14.08 7.69 8.99 12.24
Operating Cash Flow Coverage Ratio
11.87 8.04 1.57 0.23 0.12
Operating Cash Flow to Sales Ratio
0.29 0.38 0.70 0.28 0.29
Free Cash Flow Yield
1.45%-0.35%10.64%2.73%3.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-18.37 23.69 -215.90 44.96 -539.23
Price-to-Sales (P/S) Ratio
13.49 9.41 5.74 9.27 8.63
Price-to-Book (P/B) Ratio
3.06 1.76 1.89 3.13 2.27
Price-to-Free Cash Flow (P/FCF) Ratio
68.97 -289.19 9.40 36.68 32.11
Price-to-Operating Cash Flow Ratio
46.12 24.92 8.17 32.60 29.49
Price-to-Earnings Growth (PEG) Ratio
<0.01 -0.02 1.98 -0.02 5.36
Price-to-Fair Value
3.06 1.76 1.89 3.13 2.27
Enterprise Value Multiple
-19.70 12.09 22.32 21.67 29.20
Enterprise Value
2.41B 1.22B 1.21B 2.89B 2.02B
EV to EBITDA
-19.70 12.09 22.32 21.67 29.20
EV to Sales
13.25 9.28 6.19 10.41 10.82
EV to Free Cash Flow
67.74 -285.26 10.13 41.20 40.23
EV to Operating Cash Flow
45.54 24.58 8.81 36.62 36.94
Tangible Book Value Per Share
22.70 13.33 8.25 4.60 -5.34
Shareholders’ Equity Per Share
41.45 40.52 35.42 49.41 43.84
Tax and Other Ratios
Effective Tax Rate
0.18 0.15 1.14 -0.22 0.72
Revenue Per Share
9.46 7.59 11.63 16.66 11.52
Net Income Per Share
-6.91 3.02 -0.31 3.44 -0.18
Tax Burden
0.82 0.82 -0.14 1.21 0.28
Interest Burden
1.02 0.99 0.95 0.52 -0.37
Research & Development to Revenue
0.36 0.19 0.18 0.25 0.32
SG&A to Revenue
0.48 0.40 0.36 0.21 0.35
Stock-Based Compensation to Revenue
0.29 0.20 0.31 0.14 0.16
Income Quality
-0.40 0.95 -4.13 1.38 -18.29
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis